Subscribe to Portfolio Insight and Save!

Use my affiliate link to sign up for a free 14-day, no-obligation trial of Portfolio Insight. No credit card required. If you decide to subscribe during the trial period, you'll receive a 20% discount on the first year's annual subscription price of $330. Please note the 20% affiliate discount does not apply to the monthly rate.

Monday, December 23, 2019

Dividend Increases: December 16-20, 2019

Monitoring dividend increases for stocks on my watch is one way to identify candidates for further analysis. Companies that regularly raise their dividend payments show confidence in future earnings growth potential.

I look for dividend increase announcements for stocks in the Dividend Champions List [CCC list]. This week, 8 companies in the CCC list announced dividend increases, including two of the stocks I own.

Three of this week's dividend increases are double-digit percentage increases!

The top increase this week is from Eli Lilly (LLY), a company that discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. LLY announced a strong increase of 15% and now yields 2.29% at $132.43 per share.

To see details of all the increases announced last week, please read this article at Seeking Alpha.

As a bonus, I'm including a summary of ex-dividend dates for the next two weeks. Scan the list of stocks to see if there's a stock you want to pick up before the ex-dividend date so you can grab the next dividend. 

Thanks for reading! Please subscribe to receive an e-mail whenever I post new articles.
Soon sections of my blog will only be available to subscribers, so I encourage you to sign up now!

No comments :

Post a Comment

Please don't include links in comments. I will mark such comments as spam and the comment won't be published. To make me aware of your blog or website, comment on my Blogrole page instead.